𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The neuroprotective effects of Cerebrolysin™ in a transgenic model of Alzheimer’s disease are associated with improved behavioral performance

✍ Scribed by E. Rockenstein; A. Adame; M. Mante; H. Moessler; M. Windisch; E. Masliah

Publisher
Springer
Year
2003
Tongue
English
Weight
552 KB
Volume
110
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Noninvasive in vivo MRI detection of neu
Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease
✍ G. Vanhoutte; I. Dewachter; P. Borghgraef; F. Van Leuven; A. Van der Linden 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

## Abstract Transgenic mice overexpressing the London mutant of human amyloid precursor protein (APP[V717I]) in neurons develop amyloid plaques in the brain, thus demonstrating the most prominent neuropathological hallmark of Alzheimer's disease. In vivo 3D __T__~2~\*‐weighted MRI on these mice (24

Olanzapine versus placebo in the treatme
Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease
✍ Peter Paul De Deyn; Manuel Martín Carrasco; Walter Deberdt; Claude Jeandel; Dona 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

## Abstract ## Objectives Psychotic symptoms and behavioral disturbances are a concern in the care of elderly patients with Alzheimer's dementia (AD). This study was conducted to compare the efficacy of olanzapine versus placebo in patients with psychotic symptoms associated with AD in long‐term o